Tag Archives: mesothelioma clinical trials

Mesothelioma Clinical Trials: Study Highlights Challenges for Patients

mesothelioma clinical trials

A new UK study points to some of the potential challenges and benefits for patients involved in mesothelioma clinical trials.  Researchers at three teaching hospitals in England interviewed mesothelioma patients who took part in the Mesothelioma and Radical Surgery (MARS 2) trial.  The trial compared outcomes in people who had a combination of surgery and chemotherapy with those who only had chemotherapy. The findings show that not all aspects of mesothelioma clinical trials are positive for patients.  A Study Within a Study Pleural mesothelioma is a fast-growing cancer that starts on the lining around the lungs. Asbestos exposure is usually the cause. With standard cancer treatments, most mesothelioma patients face a poor prognosis. Mesothelioma often leads to death within a … Continue reading Mesothelioma Clinical Trials: Study Highlights Challenges for Patients »

Mesothelioma Clinical Trials Always Recruiting

Malignant pleural mesothelioma is an aggressive cancer with a poor prognosis.  Because it spreads quickly and there is no single cure with standard therapies, participating in a clinical trial can be one way for mesothelioma patients to access promising treatments without waiting for FDA approval. Every clinical trial has its own set of requirements for participation. Some are open to newly diagnosed mesothelioma patients while others are reserved for those who have failed to respond to other treatments.  Participants usually must agree to a full physical exam, including urine and blood samples, and must agree to follow study protocols and have regular follow-up appointments. The National Cancer Institute provides a online database of clinical trials for mesothelioma and every other cancer.  Currently … Continue reading Mesothelioma Clinical Trials Always Recruiting »

Spice May Trigger Mesothelioma Cell Breakdown

There’s more evidence that cancer researchers might do well to spice up their mesothelioma clinical trials. A team of researchers at Keio University in Tokyo report that curcumin, the primary component in the spice turmeric, can effectively reduce the viability of human mesothelioma cells in the laboratory. This, despite the fact that mesothelioma is notoriously resistant to many types of conventional cancer therapies. “Curcumin, which has a long history as a dietary spice, is known to suppress the growth of multiple cancer lines, but the effects on mesothelioma cells are not well-defined,” observed principal investigator Y. Yamauchi in Phytotherapy Research. Mesothelioma is an aggressive cancer of internal membranes, triggered by asbestos exposure. Citing mesothelioma’s well-known treatment resistance, Yamauchi says alternative … Continue reading Spice May Trigger Mesothelioma Cell Breakdown »

More Than Thirty Mesothelioma Clinical Trials Are Underway

Clinical trials are human studies of new drugs and treatments to determine whether or not they should be approved by the FDA. Clinical trials for mesothelioma are ongoing, primarily at major medical centers around the country. Because mesothelioma is an aggressive cancer, many trials are focused on ways to detect it earlier and treat it more effectively with various combinations of therapies. Although participation in a mesothelioma trial may sound like a good way to connect with promising new treatments, not every mesothelioma patient is a candidate. Because clinical trials are established with specific goals, most have very specific guidelines as to the type of patients they are willing to treat. For example, some trials only accept patients who have … Continue reading More Than Thirty Mesothelioma Clinical Trials Are Underway »